<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TAS_Taipei_Composite_Part skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TAS Taipei/Composite Part</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>TAS_Taipei</TITLE></P><DIV class="navbar"><A class="pro" href="https://2018.igem.org/Team:TAS_Taipei/Description">Project</A><A class="exp" href="https://2018.igem.org/Team:TAS_Taipei/Experiments">Experiments</A><A class="prot" href="https://2018.igem.org/Team:TAS_Taipei/Applied_Design">Prototype</A><A class="mod" href="https://2018.igem.org/Team:TAS_Taipei/Model">Modeling</A><A class="hp" href="https://2018.igem.org/Team:TAS_Taipei/Human_Practices">Human Practices</A><A class="safe" href="https://2018.igem.org/Team:TAS_Taipei/Safety">Safety</A><A class="as" href="https://2018.igem.org/Team:TAS_Taipei/Team">About Us</A><A class="att" href="https://2018.igem.org/Team:TAS_Taipei/Attributions">Attributions</A></DIV><DIV class="row"><H1 class="col-lg-12 col-lg-offset-3 paddingremovaly" id="aboutourschool">BEST NEW COMPOSITE PART</H1></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">
Our best new composite part is <A href="http://parts.igem.org/Part:BBa_K2539101" target="_blank">BBa_K2539101</A>, constitutively expressed HIS-tagged ALDH2*1.
   </H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">
ALDH2*1 is the wild type form of human mitochondrial acetaldehyde dehydrogenase (ALDH2). ALDH2 is the enzyme responsible for oxidizing acetaldehyde, a toxic intermediate of alcohol metabolism, into harmless acetate (Larson <I>et al.</I>, 2005; Farrés <I>et al.</I>, 1994). Using the HIS-tagged form, we were able to purify HIS-ALDH2*1 and test its enzymatic activity under simulated oral conditions. Our results show that purified ALDH2*1 metabolizes significantly more acetaldehyde compared to the mutant form ALDH2*2. The design and characterization of BBa_K2539101 are documented below.
   </H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 bigthannormal paddingremovaly"><B>Construct Design</B></H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">For protein purification, we added a HIS-tag (6xHIS) to the N-terminus of the ALDH2*1 sequence (basic part is BBa_K2539150). This was flanked by a strong promoter and strong RBS combination (BBa_K880005) and a downstream double terminator (BBa_B0015) to maximize expression.</H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 bigthannormal paddingremovaly"><B>PCR Check Results</B></H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">The part was confirmed by PCR using the primers VF2 and VR, as well as sequencing by Tri-I Biotech.</H6></DIV><DIV class="row col-lg-offset-3 image_container col-lg-3 imagebox"><H5 class="subtitle"><B>PCR check for BBa_K2539101 using VF2 and VR primers.</B> Using these primers, PCR produced a band at the expected size of 2.1 kb. (Cloning &amp; Figure: Catherine C)</H5></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 bigthannormal paddingremovaly"><B>Characterization</B></H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly"><B>Protein Purification:</B></H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly"><I>E. coli</I> carrying BBa_K2539101 was lysed and run through a nickel column (GE Healthcare, 11-0033-99). HIS-tagged proteins should bind to the column, which contains nickel ions. SDS-PAGE was used to check protein content at different steps of the purification process: lysed cell sample, flow-through after the wash buffer, and final eluate containing the purified protein (shown below). HIS-tagged ALDH2 should be around 56 kDa. In the initial cell lysate lane, there is a band around 56 kDa. This band disappears in the wash buffer flow-through lane, and reappears in the eluate. This shows that we are able to purify HIS-tagged ALDH2*1.</H6><DIV class="row col-lg-offset-3 image_container col-lg-3 imagebox"><H5 class="subtitle"><B>SDS-PAGE results show the proteins present at different steps of protein purification.</B> A band around 56 kDa in the cell extract (green) and the eluate (red), but not present in the wash buffer flow-through lane (yellow), matches our expected HIS-tagged ALDH2*1 (BBa_K2539101). (Protein Purification/Gel &amp; Figure: Leona T, Justin W, Catherine C)</H5></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly"><B>Enzyme Activity Test:</B></H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">We tested the enzyme activity of HIS-tagged ALDH2*1 (BBa_K2539101). When ALDH2 converts acetaldehyde into acetate, NADH is produced. To test the ability of recombinant ALDH2*1 to metabolize acetaldehyde, we used reagents from a kit (Megazyme, K-ACHYD) to quantify the amount of NADH produced by taking absorbance readings at 340 nm. This wavelength is highly absorbed by the reduced form, NADH, but not the oxidized form, NAD+ (Harimech <I>et al.</I>, 2015; McComb <I>et al.</I>, 1976). High absorbance values would indicate more conversion of acetaldehyde into acetate.</H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">We saw a clear difference between the activity levels of HIS-ALDH2*1 (BBa_K2539101) and HIS-ALDH2*2 (BBa_K2539201). Purified HIS-ALDH2*2 did not have any effect on NADH, while purified HIS-ALDH2*1 significantly increased NADH levels.</H6></DIV><DIV class="row col-lg-offset-3 image_container col-lg-3 imagebox"><H5 class="subtitle"><B>Purified HIS-ALDH2*1 has a much higher activity level compared to purified HIS-ALDH2*2.</B> The enzymatic activity of purified HIS-ALDH2*1 and HIS-ALDH2*2 were tested at 25°C. A negative control containing only elution buffer (from the protein purification process) was also included (gray). HIS-ALDH2*1 steadily metabolized more acetaldehyde compared to both HIS-ALDH2*2 and the negative control, both of which did not seem to have any effect. The error bars represent standard error. (Experiment &amp; Figure: Justin W)</H5></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 bigthannormal paddingremovaly"><B>References</B></H6></DIV><DIV class="row"><H6 class="col-lg-8 col-lg-offset-3 description paddingremovaly">
Harimech PK, Hartmann R, Rejman R, del Pino P, Rivera-Gila P, Parak WJ. (2015). Encapsulated enzymes with integrated fluorescence-control of enzymatic activity. J. Mater. Chem. B. 3, 2801-2807. 

McComb RB, Bond LW, Burnett RW, Keech RC, Bowers, GN Jr. (1976). Determination of the molar absorptivity of NADH. Clin Chem. 22(2): 141–150. 
   </H6></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>